Zhaoqing Fan

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients

Jie Sun, Hua Meng, Lu Yao et al. · Clinical Cancer Research · 2017 · 270 citations · Full text

Life Sciences, Genetics, Oncology +17

Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer

Liang Shi, Bin Dong, Zhongwu Li et al. · Journal of Clinical Oncology · 2009 · 217 citations · Full text

Medicine, Cancer Biology, Oncology +17

Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment

Ye Xu, Yu Sun, Lei Yao et al. · Annals of Oncology · 2008 · 179 citations

Medicine, Oncology, Pharmacology +10

p53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer

Ye Xu, Lihua Yao, Tao Ouyang et al. · Clinical Cancer Research · 2005 · 102 citations

Medicine, Molecular Genetics, Oncology +15